NEW : Bertin Pharma’s Bioreagents activity merges with Bertin Technologies allowing the birth of the new brand Bertin Bioreagent.
Bertin Pharma’s pharmaceutical development operations have been sold to Amatsigroup and its pre-clinical and clinical research operations to the Oncodesign Group.